Quick verdict
For budget and cash-pay simplicity, Embody wins: it's an all-in, flat monthly price for compounded semaglutide or tirzepatide with no insurance, no separate membership fee, and no price hike as your dose climbs — making it one of the cheapest online weight-loss injection options. For FDA-approved branded medication and insurance help, Ro (Ro Body) wins: it prescribes brand-name Wegovy, Zepbound and Ozempic and layers an insurance concierge on top, which can unlock far lower covered prices — but you pay a recurring membership fee plus the drug's pharmacy cost. The honest bottom line: this isn't "which is better" so much as "which model fits you" — pay one low flat fee for a compounded version (Embody), or pay more for the actual FDA brand with insurance support (Ro).
If you've searched embody vs ro weight loss you've probably noticed the two programs barely seem to belong in the same comparison — and that's the point. They represent the two fundamentally different ways to get a GLP-1 online in the US in 2026: the cash-pay compounded specialist (Embody) and the branded, insurance-navigating platform (Ro Body). Picking between them isn't about which has a nicer app; it's about which business model matches your budget, your insurance situation, and whether you specifically want the FDA-approved brand or are comfortable with a compounded equivalent. This guide breaks down the real differences — cost, medications, safety, intake, and support — so the embody glp-1 vs ro body decision comes down to facts, not marketing.
| At a glance | Embody | Ro (Ro Body) |
|---|---|---|
| Model | Cash-pay compounded specialist | Membership + branded meds + insurance |
| Medication type | Compounded semaglutide & tirzepatide | FDA-approved Wegovy, Zepbound, Ozempic |
| Price structure | One flat monthly price, medication included | Membership fee plus separate drug cost |
| Typical monthly cost | ~$49–$99/mo all-in (promo pricing current) | ~$149/mo membership + drug (or far less if insured) |
| Insurance | Not needed; not used | Concierge checks and pursues coverage |
| Intake | Fast, mostly asynchronous | Async + insurance/prior-auth workflow |
| Best for | Lowest flat cash price, no insurance hassle | Getting the FDA brand, using insurance |
2026 snapshot from our live provider data — verify current pricing at checkout. See our full Embody review and Ro review, or the quick Embody vs Ro head-to-head.
How Embody and Ro actually work (core model differences)
Before any price comparison makes sense, you have to understand that Embody and Ro are selling two different things. They both end with a GLP-1 and weight loss, but how they get you there — and what you're paying for — could hardly be more different.
Embody is a cash-pay compounded specialist. Its whole model is built around one idea: skip insurance entirely, charge one flat monthly price, and include the medication in that price. You pay Embody directly, a partner compounding pharmacy prepares compounded semaglutide or tirzepatide, and it ships to your door. There's no membership fee layered on top of a separate drug bill — the number you see is, broadly, the number you pay. This is the model that makes compounded specialists the cheapest online weight-loss injection route for most cash payers, and it's why Embody's embody glp1 pricing monthly looks so much lower than a branded program's: you're buying a compounded version, cash, with the medication bundled in.
Ro (Ro Body) is a membership platform that prescribes the real brands and works your insurance. Ro's model has two parts that are billed separately, which trips people up constantly. First, there's the Ro Body membership — a recurring platform fee that pays for the clinician access, the app, coaching tools, and crucially the insurance concierge. Second, there's the medication itself, which is FDA-approved brand-name Wegovy, Zepbound or Ozempic, billed through a pharmacy and priced separately — sometimes covered by insurance for very little, sometimes paid cash at manufacturer self-pay prices. Ro's pitch isn't "cheapest"; it's "we'll get you the actual FDA brand and fight to get your insurance to pay for it." That insurance-navigation piece is the real product, and it's why people who have coverage often end up paying less through Ro than they would cash-paying for compounded elsewhere.
Here's the cleanest way to hold the difference in your head. Embody sells you a low, predictable, all-in cash price for a compounded medication. Ro sells you access to the FDA brand plus the expertise to use your insurance. One optimizes for simplicity and low cash cost; the other optimizes for branded medication and coverage. Neither is a trick — they're honest answers to different questions. If you have no coverage for weight-loss drugs (as many people don't) and want the lowest reliable monthly outlay, the compounded cash model is built for you. If you have insurance that might cover a GLP-1, or you specifically want the brand-name pen that matches the clinical trials, the membership-plus-insurance model is built for you.
This core split also explains a lot of the secondary differences you'll see below. Because Embody doesn't touch insurance, its intake can be faster and lighter. Because Ro's value is partly the insurance work, its process includes a coverage check and sometimes a prior-authorization battle that takes longer but can pay off big. Because Embody bundles the drug into a flat fee, there are no surprise pharmacy bills; because Ro splits membership from medication, you have to add two numbers to know your real cost. Keep the model difference in mind and every other comparison in this guide falls into place.
Cost breakdown and hidden fees
This is where most people's decision actually gets made, so let's be precise and honest — including about the parts the marketing glosses over. All figures are a 2026 snapshot; promotions and prices move, so confirm the current numbers before you commit.
Embody's cost: one flat line. Embody prices as an all-in monthly figure with the medication included. As of this writing it's running a promotional flat ~$49/month for compounded semaglutide (and around $99/month for compounded tirzepatide), with typical ongoing month-to-month pricing landing higher — in the high-$70s to around $129 depending on plan length and which medication. The key feature is flat-rate titration: the price doesn't rise as your dose increases. On a brand program, moving to a higher dose can mean a bigger pharmacy bill; on a flat compounded plan, the monthly price is the monthly price whether you're at a starter dose or a maintenance dose. That predictability is a genuine advantage of the compounded cash model, and a core reason embody glp1 pricing monthly stays low and stable. (The one thing to confirm directly: the program's maximum available dose, since compounded programs can differ on how high they'll titrate.)
Ro's cost: two bills, and the honest math. Ro's total is membership + medication, and you have to add both. The Ro Body membership cost is about $149/month on a monthly plan (with a $39 first month, and a discounted rate — around $74/month — if you prepay annually). That fee does not include the drug. Then there's the medication, and this is where it splits hard depending on insurance:
- With insurance that covers a GLP-1: the drug can cost very little — many covered Ro members pay around $25–$50/month for Wegovy or Zepbound — so your real total is roughly the membership plus that small copay. This is the scenario where Ro beats cash-pay compounded outright.
- Paying cash for the brand (no coverage): this is the ro wegovy cash price without insurance situation, and it's not cheap. Branded Wegovy through Ro runs around the manufacturer self-pay level — roughly $349/month for the pen (with a $199 introductory price advertised for eligible early fills), and branded Zepbound roughly $299–$449/month by dose. Add the ~$149 membership and a cash-pay branded total can land in the $450–$600/month range.
Putting it into a six-month estimate makes the gap concrete. These are illustrative 2026 snapshots, not quotes:
| 6-month estimate (illustrative) | Membership | Medication | Approx. total |
|---|---|---|---|
| Embody (compounded, cash, promo) | $0 (none) | Included in flat fee | ~$300–$550 |
| Ro — insured (GLP-1 covered) | ~$450–$900 | ~$150–$300 copays | ~$600–$1,200 |
| Ro — cash, branded | ~$450–$900 | ~$1,800–$2,400 | ~$2,300–$3,300 |
Illustrative only; actual totals depend on plan length, dose, promotions and your specific insurance. Verify every figure at checkout. Embody's range reflects promo vs typical month-to-month pricing; Ro's insured range depends entirely on your plan's coverage.
The hidden-fee watch-list, for both. On Ro, the trap is forgetting the membership is separate from the drug — a "$199 Wegovy" headline doesn't include the ~$149 membership on top, so always add both, and remember the $199 is an intro that steps up to ~$349. On Embody (and any compounded cash program), the trap is the intro-vs-ongoing gap: a promotional first-month or first-few-months rate that rises to a higher standard price later, so confirm the ongoing monthly price, not just the sign-up teaser. Both programs are legitimate about this if you read the terms; the mistakes come from comparing a teaser on one side to a full price on the other. Our GLP-1 cost guide keeps the current landscape updated, and what to ask before you prepay covers the refund and cancellation questions to settle first.
The honest cost summary: if you're paying cash and don't need the brand, Embody is dramatically cheaper — often a few hundred dollars across six months versus a few thousand for cash-pay branded through Ro. If your insurance covers a GLP-1, Ro can be the cheaper and better option, because the concierge may unlock a ~$25–$50 covered drug price that no cash compounded plan can match once you value the FDA brand. The deciding variable is almost always your insurance: check it first, because it flips the answer.
Medication options: compounded vs FDA brand name
The price gap above isn't arbitrary — it comes straight from what each program dispenses. This is the single most important thing to understand before choosing, because it's a genuine trade-off, not a marketing distinction. The whole compounded semaglutide vs brand wegovy question lives here.
Embody dispenses compounded GLP-1s. Compounded semaglutide and tirzepatide use the same active molecules as the brands — semaglutide is the drug in Wegovy and Ozempic; tirzepatide is the drug in Zepbound and Mounjaro — but they're prepared by a compounding pharmacy rather than manufactured and FDA-approved as a finished product. That distinction is the crux: compounded drugs are not FDA-approved, meaning they haven't been through the agency's review for safety, effectiveness, and manufacturing consistency the way the brands have. The FDA has publicly flagged its concerns with unapproved GLP-1 drugs used for weight loss, and its overview of drug compounding explains how compounding is regulated. Compounding is legal and long-established, and many licensed pharmacies do it carefully — but the quality floor is the pharmacy's, not the FDA's. With a compounded program, who prepares your medication matters more than with a brand, which is why vetting the pharmacy is on you.
Ro dispenses FDA-approved brand-name medication. When Ro prescribes Wegovy or Zepbound, you're getting the exact products that went through the pivotal trials, made by Novo Nordisk and Eli Lilly under FDA manufacturing standards, in a known device at a known dose. That's what the higher price buys: regulatory approval, manufacturer quality control, and the specific formulation the evidence is built on.
The clinical context, briefly (and why it's reassuring either way). The weight-loss results you've seen headlines about come from trials of the branded molecules: semaglutide in the STEP program (STEP 1, NEJM 2021, ~14.9% average body-weight loss) and tirzepatide in the SURMOUNT program (SURMOUNT-1, NEJM 2022, up to ~21%), with a head-to-head (SURMOUNT-5, NEJM 2025) showing tirzepatide outperforming semaglutide. Compounded versions use the same molecules, so the underlying pharmacology is the same — but the trial evidence is for the FDA-approved products specifically. That's an honest nuance: a compounded semaglutide is chemically the same drug the trials studied, yet it wasn't the exact product tested or approved. For a fuller breakdown see our guide on compounded vs brand-name vs pills and tirzepatide vs semaglutide.
The FDA shortage context matters here too. Compounded GLP-1s surged during the brand-name shortages, when compounding of otherwise-approved drugs is more permitted; as those shortages resolved, the rules tightened and the compounded market narrowed and came under more scrutiny. That's a live, shifting regulatory picture — we track it in is compounded semaglutide still legal — and it's exactly why choosing a licensed, transparent compounded program (rather than the cheapest anonymous one) matters more now than it did at the peak. It's also part of why some big names have changed their models: platforms that once sold compounded semaglutide have, after regulatory and legal pressure in 2026, shifted toward dispensing the FDA brands instead.
On the dose question and the "injection vs pill" angle. Both compounded and branded routes titrate the dose up over time. A flat-rate compounded plan like Embody's has the pricing advantage that stepping up the dose doesn't raise your bill, whereas branded pharmacy costs can change by dose. The thing to confirm with any compounded program is the maximum dose it will provide, since that can vary. Separately, if needles are a dealbreaker, note that semaglutide now also comes as an oral pill — the glp-1 injection vs weight loss pill cost comparison is its own topic (the pills carry their own pricing and trade-offs), covered in our weight-loss pill guide. For the Embody-vs-Ro decision, though, the core contrast is compounded injection (Embody) vs FDA-brand injection, with Ro also able to prescribe branded oral options.
So how should you weigh it? Branded (via Ro) buys FDA approval, manufacturer quality, and the exact trial-tested product — for more money, especially without insurance. Compounded (via Embody) buys the same core molecule at a fraction of the cash price — at the cost of FDA approval and with real variability in pharmacy quality, so vetting matters. If you can get the brand covered by insurance for a small copay, that's usually the stronger choice; if you're paying cash and brand pricing is out of reach, a carefully vetted compounded program is how many people access treatment they otherwise couldn't — with eyes open about the trade-off.
Consultation process and intake speed
How you actually get started differs in ways that match each program's model — and the speed difference is real, though it's a feature of the trade-off, not simply one being "better."
Embody: fast, mostly asynchronous. Because Embody doesn't deal with insurance, its intake is built for speed. You complete a medical questionnaire online, a licensed clinician reviews it (asynchronously, without a scheduled live appointment for most people), and if appropriate, a prescription goes to the partner compounding pharmacy, which ships the medication to you. There's no insurance verification step to slow things down, which is why cash-pay compounded programs typically get people started fastest — often within days. The trade-off is that a lighter, async process means less built-in hand-holding; you need to be comfortable managing a weekly injection with messaging-based support rather than scheduled video visits.
Ro: async clinician review plus an insurance workflow. Ro also uses an online intake and asynchronous clinician review, but its process includes the piece that defines its value — the insurance check and, where needed, prior authorization. Ro will run a coverage check (the ro glp1 insurance coverage check step) to see what your plan will do, and if a GLP-1 requires prior authorization, Ro's team helps pursue it. That extra workflow takes longer than a pure cash intake, and prior authorizations can add days or weeks depending on your insurer — but it's time spent potentially saving you hundreds of dollars a month. So the intake-speed comparison is really a restatement of the model difference: Embody is faster because it skips insurance; Ro is slower partly because it's doing the insurance work that can make the brand affordable.
What's similar. Both are legitimate telehealth programs that require a genuine clinician in the loop — a real medical review, not just a payment form — and both handle the logistics (shipping, refills) so you're not chasing a local pharmacy. Both involve the standard GLP-1 titration schedule, stepping the dose up over months. Neither typically requires an in-person visit, though lab work may be requested depending on your history, which is normal and a good sign a program is taking safety seriously.
The practical takeaway: if your priority is starting as fast and simply as possible and you're paying cash, Embody's lighter async model is built for that. If your priority is getting insurance to pay and you're willing to spend a little longer up front, Ro's workflow is built for that. As with cost, the "right" intake depends on whether you're optimizing for speed-and-simplicity or coverage-and-brand.
Where Hims, Henry Meds and the other big names fit
Embody and Ro are the two clearest examples of the two models, but they're not the only players, and people searching embody vs hims weight loss injection or weighing other brands deserve honest context on where those fit — without us inventing numbers we can't stand behind, so treat this as orientation and verify current specifics with each company.
Hims is worth understanding because it recently changed lanes. Hims built much of its weight-loss growth on compounded semaglutide — the same low-cost cash model as Embody — but after a 2026 settlement with Novo Nordisk and broader regulatory pressure on compounded GLP-1s, it shifted toward offering the FDA-approved brands (Wegovy, Ozempic) at manufacturer self-pay prices alongside a recurring membership. In other words, Hims moved from looking like Embody (compounded, cash, cheap) toward looking more like Ro (branded, membership, higher cost). So an embody vs hims comparison today is increasingly a comparison between a compounded cash specialist and a branded-membership platform — much like Embody vs Ro — rather than two cheap compounded programs. Confirm Hims' current medication and pricing directly, since this space moved fast in 2026.
Henry Meds is often mentioned in the same breath as Embody because it's another well-known compounded GLP-1 specialist with a flat cash-pay model — the same category, optimizing for low monthly cost without insurance. Calibrate sits closer to Ro's end: a more intensive, coaching-and-insurance-oriented program centered on branded medication and behavior change, at a higher price point. The pattern across all of them is the same two-model split this guide is built on: compounded-cash specialists (Embody, Henry Meds, formerly Hims) versus branded/insurance platforms (Ro, Calibrate, increasingly Hims). Once you see which model a program follows, its pricing and process stop being surprising.
If you want the best online GLP-1 provider in the US for your situation, the useful move isn't to chase a single brand name — it's to decide which model fits (cash-pay compounded vs branded-with-insurance), then pick the best-run program in that category. Here are the programs we rate most highly to start with, spanning both models; our rankings are independent, and how we score and make money is linked below.
9.8/10Compounded GLP-1 injections at a flat $49/mo on embody's current sale.
Visit embody Read our full review
9.4/10The most established, most transparent option — a full FDA-approved suite (Wegovy, Zepbound, Ozempic, Foundayo) with a dedicated insurance concierge.
Visit ro Read our full review
9.6/10Compounded GLP-1 at one flat price — $99 semaglutide, $129 tirzepatide, the same every month.
Visit Eden Read our full reviewOur picks among online GLP-1 programs. Rankings and reviews are decided independently; we may earn a commission from some providers, which can affect placement but not our scores. How we make money · How we score.
You can compare the full field — compounded and branded — in our provider reviews and head-to-head comparisons, and see how everyone ranks on our main comparison.
Embody vs Ro: the full head-to-head
Everything above, in one scannable table. As always, treat prices as a 2026 snapshot to verify.
| Metric | Embody | Ro (Ro Body) |
|---|---|---|
| Core model | Cash-pay compounded specialist | Membership + branded meds + insurance concierge |
| Medication | Compounded semaglutide & tirzepatide | FDA-approved Wegovy, Zepbound, Ozempic |
| FDA-approved drug? | No (compounded) | Yes (brand-name) |
| Price structure | One flat monthly price, med included | ~$149/mo membership + separate drug cost |
| Typical monthly cost | ~$49–$129/mo all-in | ~$174/mo insured (membership + copay) to ~$500+/mo cash-branded |
| Titration & pricing | Flat rate — price doesn't rise with dose | Drug cost can vary by dose |
| Insurance support | None (cash-pay by design) | Coverage check + prior-authorization help |
| Intake speed | Fast, mostly asynchronous | Async + insurance workflow (slower, can pay off) |
| Support style | Messaging-based clinician support | Clinician access, app, coaching tools |
| Best for | Lowest flat cash price; no insurance hassle | Getting the FDA brand; using insurance |
| Watch out for | Intro-vs-ongoing price gap; confirm max dose | Two separate bills; cash-branded totals are high |
From our live provider data and 2026 research. Confirm current pricing and terms at each provider's checkout. Full detail in our Embody review and Ro review.
Which should you choose?
The decision gets simple once you sort it by your own situation. Work down this list; the first factor that's decisive for you usually settles it.
Choose Embody if: you have no insurance coverage for weight-loss drugs (or don't want to deal with insurance at all), you want the lowest predictable monthly cost, you're comfortable with a compounded version of the medication from a licensed program, and you value a fast, simple, cash-pay start. For the large number of Americans whose plans exclude weight-loss medications, this is often the only affordable path to a GLP-1 — and the flat, dose-stable pricing makes budgeting easy. If your question is cheapest online weight-loss injection, the compounded cash model is the answer, and Embody is one of the strongest programs in that category.
Choose Ro if: you have insurance that might cover a GLP-1 (even partially), you specifically want the FDA-approved brand-name medication that matches the clinical trials, or you want help navigating prior authorization and coverage. If your plan covers Wegovy or Zepbound, Ro's concierge can turn a $349-a-month cash drug into a $25–$50 copay, which no cash compounded plan can beat once you factor in getting the actual brand. The membership fee pays for itself when the insurance work succeeds.
The insurance test that decides it for most people: before anything else, check whether your health plan covers a GLP-1 for weight loss. If it does, lean Ro and let the concierge pursue that coverage — the covered price usually wins. If it doesn't (very common), the math tilts hard toward a cash compounded program like Embody, because paying cash for the brand through any platform is expensive and the compounded route is a fraction of the price. That one check — does my insurance cover this? — flips the answer more reliably than any feature comparison.
And if you're genuinely torn: a reasonable default is to run Ro's free insurance/coverage check first (it costs nothing to find out what your plan will do), and if coverage comes back thin or excluded, switch your attention to a vetted cash compounded program. You're not locked in either way — many people even move between models over time as their coverage or budget changes, which is easier than it sounds and covered in the FAQ below. The worst outcome isn't picking the "wrong" one; it's paying a cash-branded price you didn't need to because you never checked your coverage, or buying compounded from a program that skips the medical part to shave a few dollars.
Embody vs Ro: frequently asked questions
Is Embody weight loss legit and safe?
Embody is a legitimate telehealth weight-loss program: it uses a licensed clinician to review your intake and prescribes compounded semaglutide or tirzepatide through a partner compounding pharmacy. The honest nuance on safety is that compounded GLP-1s aren't FDA-approved — they use the same active molecule as Wegovy or Zepbound, but they're prepared by a compounding pharmacy rather than manufactured under FDA approval, so quality depends on that pharmacy rather than the agency's review. That makes vetting the program important, and it's why a real medical intake (not just a payment form) matters. Used through a licensed, transparent program, it's a mainstream way many cash-paying Americans access GLP-1 treatment; see our full Embody weight loss review and our guide on spotting a legit online clinic.
What is the cheapest online weight loss injection provider in the US?
The cheapest route is almost always a cash-pay compounded program, not a branded platform — compounded semaglutide runs a fraction of brand-name cash prices because you're skipping the FDA-approved product and the insurance layer. Programs like Embody advertise flat all-in pricing that can start under $100/month and often lower on promotions, with the medication included. The important caveat is to compare the ongoing monthly price (not just a sign-up teaser) and to choose a licensed program rather than the absolute cheapest anonymous one. If you have insurance that covers a GLP-1, though, a covered brand through a platform like Ro can actually be cheaper than cash compounded — so check your coverage first. See the current field in our provider rankings.
Does Ro cover the cost of Wegovy if my insurance denies it?
No — Ro isn't an insurer and doesn't pay for your medication. What Ro does is help you pursue coverage: it runs an insurance check and, where a GLP-1 needs prior authorization, its team helps with that process. If your insurance ultimately denies coverage, you'd pay the cash self-pay price for the brand (roughly $349/month for Wegovy, or $299–$449 for Zepbound by dose, as a 2026 snapshot) on top of Ro's membership. So Ro can improve your odds of getting covered and handle the paperwork, but it can't force an insurer to pay, and a denial means cash-pay branded pricing. If that's out of budget, a cash compounded program becomes the realistic alternative.
Can you switch from brand Wegovy to compounded semaglutide online (or vice versa)?
Yes, and people do it in both directions — typically moving from branded to compounded to cut cost, or from compounded to branded to get the FDA-approved product or because a program changed its offering. It's a clinical decision made with a prescriber, not a simple swap: because the two are the same molecule, the switch is usually straightforward, but your clinician will confirm the right dose and may re-confirm your intake on the new program. The main things to handle are timing (don't leave a gap in medication) and dose continuity (match where you are in your titration). It's one reason not to over-stress the initial Embody-vs-Ro choice — you retain the option to move between the cash-compounded and branded-insurance models as your budget or coverage changes.
Is compounded semaglutide as effective as brand-name Wegovy?
It's the same active molecule — semaglutide — so the underlying pharmacology is the same, and the compounded tirzepatide vs Zepbound comparison works the same way. The honest distinction is regulatory, not chemical: the clinical-trial evidence and FDA approval are for the branded products specifically, while compounded versions aren't FDA-approved and their quality depends on the compounding pharmacy. In practice, a properly prepared compounded semaglutide delivers the same drug the trials studied; the trade-off you're accepting is the loss of FDA approval and manufacturer quality control in exchange for a much lower cash price. Vetting the pharmacy is how you manage that trade-off — see compounded vs brand-name vs pills.
How do I get a Wegovy pen online in the US?
To get a genuine branded Wegovy pen online, you need a platform that prescribes FDA-approved medication and routes it through a pharmacy — Ro is the example in this guide, and it adds an insurance check to try to lower the cost. The process is: complete an online intake, have a licensed clinician review it, run a coverage check, and then either fill through insurance (potentially a small copay) or pay the manufacturer self-pay price (roughly $349/month as a 2026 snapshot, with an advertised $199 introductory price for eligible early fills). A cash-pay compounded program like Embody, by contrast, doesn't dispense the branded Wegovy pen at all — it ships compounded semaglutide, which is the cheaper, non-FDA-approved alternative. So the route depends on whether you specifically want the brand pen (branded platform) or the lowest cash price (compounded program).
The bottom line
Embody vs Ro isn't really a contest between two similar products — it's a choice between two models, and the right one depends almost entirely on your insurance and whether you want the FDA brand. If you're paying cash and want the lowest, most predictable monthly price for a GLP-1, Embody's flat compounded model is hard to beat and far cheaper than cash-paying for the brand anywhere. If you have insurance that might cover a GLP-1, or you specifically want the FDA-approved Wegovy or Zepbound that the clinical trials were built on, Ro's membership-plus-insurance model is worth the extra cost because the concierge can unlock a covered price no compounded plan can match.
So do the one thing that settles it: check whether your insurance covers a GLP-1 for weight loss before you decide. Coverage points you to Ro; no coverage points you to a vetted cash compounded program like Embody. Either way, insist on a real clinician and transparent ongoing pricing, read the terms on refunds and cancellation, and compare the ongoing monthly cost rather than the sign-up teaser. Then compare the full field in our ranked provider comparison, read the individual Embody and Ro reviews, and browse more head-to-head matchups before you commit.